CLA

Conjugated linoleic acid · a fatty acid, weighed and declared

All articles checked for accuracy against the GB NHC Register and all sources have citations with verified links to their relevant studies.

Conjugated linoleic acid (CLA) is a group of related fatty acids found mainly in ruminant dairy and meat. WellsparQ lists it transparently on one product, in a very small amount and with a milk allergen note.

This article explains what CLA is, how supplemental CLA differs from the natural dietary forms, how WellsparQ uses it, and what European regulators have concluded. It focuses on clear, evidence-led facts and on label transparency rather than promotional claims.

Ingredient Snapshot

What it is

Conjugated linoleic acid — a group of related fatty acids found in animal fats.

Where from

Mainly ruminant sources: dairy fat, beef and lamb (and industrialised safflower/sunflower oil for supplements).

Known for

A family of linoleic acid isomers present in milk and meat; supplements usually contain a different isomer mix.

In WellsparQ

• KinetiHerb12 mg conjugated linoleic acid

CLA — conjugated linoleic acid — is not a single substance but a family of closely related fatty acids. It occurs naturally in the milk and meat of grazing animals, and it has been studied for decades, often with more enthusiasm in the headlines than in the data. At WellsparQ it appears as a small, declared line on one formula. This page explains what it is, where it comes from, and what the regulators have actually concluded — no more, no less.

What CLA is

Linoleic acid is a common dietary omega-6 fat. "Conjugated" linoleic acid is a set of its isomers — molecules with the same atoms but their double bonds rearranged into a conjugated position ^¹. Of the many possible forms, two dominate the conversation: cis-9, trans-11 (the main one found in food) and trans-10, cis-12 (the form most studied for effects on body fat) ^¹².

The natural origin is distinctive. CLA is created in the rumen of cattle, sheep and goats, where gut microbes partially hydrogenate dietary linoleic acid; it is then further made in the animal's own tissues ^². That is why the dietary sources of CLA are almost entirely ruminant products — dairy fat, beef and lamb — with the cis-9, trans-11 isomer making up roughly 80–90% of the CLA in that fat ^¹². In ordinary UK diets, milk, cheese, butter and beef are the main contributors, and intake shifts with the seasons because pasture-fed animals produce more ^¹.

Supplemental CLA is a different beast. It is typically manufactured by chemically rearranging a vegetable oil rich in linoleic acid — safflower or sunflower oil — to give a concentrated oil containing a roughly 50:50 mixture of the cis-9, trans-11 and trans-10, cis-12 isomers, quite unlike the natural dietary balance ^³. This distinction matters when reading the research: a study on a 50:50 supplement is not the same as eating cheese.

How WellsparQ uses it — and the milk note

Source: WellsparQ Supplements Database. Two honest observations follow from that number.

First, 12 mg is a very small, token amount — orders of magnitude below the multi-gram doses used in the research literature (studies typically use around 3–4 g of CLA per day) ^⁴⁵. The factsheet voice keeps this in proportion: "a fatty acid in powder form."

Second, and importantly for suitability: the WellsparQ CLA in KinetiHerb contains milk. That is why this product is vegetarian, but not vegan, and it carries a milk allergen declaration. We flag that plainly — it is exactly the kind of full-label honesty the brand treats as standard.

What the regulators concluded

This is the heart of the page, and it is unusually clear-cut for a supplement ingredient. CLA has been formally assessed by the European Food Safety Authority (EFSA), twice, on efficacy — and the answer both times was no.

• In 2010, EFSA's expert panel reviewed a broad set of proposed CLA claims — body weight, lean body mass, insulin sensitivity, antioxidant protection and immune effects — and concluded a cause-and-effect relationship had not been established for any of them ^⁴.
• In 2015, EFSA assessed a specific application for an equimolar cis-9,trans-11 / trans-10,cis-12 mixture (marketed as Clarinol® and Tonalin®) and "reduction in body fat mass". Again the opinion was unfavourable: the claim was not substantiated ^⁵.

On safety, EFSA's separate Novel Food opinions on CLA-rich oils judged them safe for the assessed uses (around 3–3.5 g CLA per day) for up to six months, while explicitly noting that longer-term safety, and safety in people with type-2 diabetes, had not been established ^⁶. In other words: even where a body-fat effect was argued, EFSA weighed it against unresolved safety questions and did not authorise a claim.

The plain reading for a UK brand: CLA has no authorised health claim, and its most-marketed claim (body fat) was specifically rejected. We report that record as fact; we do not work around it.

Safety and sensible use

For most people, CLA from ordinary food (dairy and meat) is simply part of the diet. Concentrated supplements are a different matter: the evidence base points to possible effects on blood lipids and markers of insulin sensitivity at gram-level doses, and EFSA declined to clear long-term use ^⁶. At the 12 mg present in KinetiHerb these considerations are largely academic, but the general principle stands — anyone pregnant or breastfeeding, taking medication, or managing diabetes or a metabolic condition should speak to a GP or pharmacist before using a CLA supplement.

Where it fits

CLA is a naturally occurring fatty acid with a long research trail and a firmly negative regulatory verdict on the claims most often made for it. On the WellsparQ label it is a small, declared line — named accurately, flagged for its milk content, and left to stand as what it is. Rooted in nature, and reported straight from the research.